Onfy
B2B2C marketplace for prescription-free health products at 20-60% below retail prices.
Website: https://onfy.de
Cover Block
PUBLIC
| Name | Onfy |
| Tagline | B2B2C marketplace for prescription-free health products at 20-60% below retail prices. [TechCrunch] |
| Headquarters | Berlin, Germany |
| Founded | 2021 [Bounce Watch] |
| Business Model | B2B2C |
| Industry | Healthtech |
| Technology | Software (Non-AI) |
| Geography | Western Europe |
| Founding Team | Solo Founder |
Links
PUBLIC
- Website. https://onfy.de/
- LinkedIn. https://de.linkedin.com/company/onfy
- Instagram. https://www.instagram.com/onfy.de/
- Facebook. https://www.facebook.com/onfy.de/
These links provide the primary points of public contact and content for Onfy. The company maintains a standard social media presence across major consumer platforms, consistent with its B2B2C marketplace model that interfaces directly with end-users.
Executive Summary
PUBLIC
Onfy operates a B2B2C marketplace that connects pharmacies and consumers directly to manufacturers of prescription-free health products. This model merits investor attention for its potential to capture margin in Germany's fragmented, price-sensitive online pharmacy sector.
Founded in 2021 by CEO Iana Liaskovik, the Berlin-based company has built a platform offering over 70,000 items, from medications to vitamins. Prices are claimed to be 20 to 60 percent below recommended retail on average [TechCrunch, Unknown] [Onfy.de, Unknown].
The core differentiation lies in its dual-sided network. It aggregates supply from manufacturers for pharmacy partners while also serving end consumers. This positions it as a logistics and pricing layer rather than a single retailer.
The founding team's public record is limited to Liaskovik as a solo founder. Capitalization is not publicly disclosed. This suggests a bootstrapped or early-stage venture with funding details held privately.
Over the next 12-18 months, key indicators to monitor include the scaling of its embedded financing partnership with Banxware [Banxware.com, Unknown]. Depth of pharmacy network matters too. Ability to defend discount-driven market share against established online pharmacy oligopolists will be critical.
Data Accuracy: YELLOW -- Core business model and product claims are confirmed by company sources and a sponsored article; employee count and product catalog size are from single, unverified third-party sources.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Business Model | B2B2C |
| Industry / Vertical | Healthtech |
| Technology Type | Software (Non-AI) |
| Geography | Western Europe |
| Founding Team | Solo Founder |
Company Overview
PUBLIC
Onfy GmbH was founded in Berlin in 2021. It launched its online marketplace for non-prescription health products that same November [Bounce Watch].
The company is a registered legal entity (HRB 225442 B) with headquarters in the German capital [Onfy.de, Impressum]. The founding story centers on creating a B2B2C platform to connect pharmacies directly with manufacturers. This aims to reduce costs for end consumers [TechCrunch].
Key operational milestones are sparse in public records. The primary verifiable event is the launch of www.onfy.de.
A partnership with embedded finance provider Banxware followed. It integrates financing solutions for pharmacy partners directly into the Onfy platform [Banxware.com]. This suggests a strategic focus on enabling B2B customers, the pharmacies, rather than solely pursuing end-consumer growth.
Public traction signals are limited to product catalog size and team headcount. The marketplace lists over 70,000 prescription-free items [TechCrunch]. A third-party pharmacy comparison site counted 83,664 products [Medizinfuchs.de].
The company reported a headcount of 28 employees according to a business intelligence database [RocketReach]. No funding rounds, specific customer wins, or revenue milestones are disclosed.
Data Accuracy: YELLOW -- Core entity and launch date confirmed by company registry and secondary source; partnership and scale claims are from single sources.
Product and Technology
MIXED
The core product is a B2B2C online marketplace. It connects pharmacies and consumers directly with manufacturers of prescription-free health products.
Onfy's website describes itself as a platform that brings together customers and sellers of health products. Partners list their items for sale [onfy.de].
The public-facing storefront allows consumers to order medications and health products for delivery. It aggregates inventory from multiple pharmacy partners into a single cart [LinkedIn].
For the B2B side, the platform serves as a procurement and financing tool for pharmacies. A key feature is an embedded lending solution from Banxware. It provides pharmacies with digital access to capital directly within the Onfy workflow [banxware.com].
This suggests the product aims to be more than a simple storefront. It embeds financial services to improve pharmacy liquidity. The technology stack is not detailed publicly.
The presence of customer review modules, blog content, and a multi-vendor cart system implies a standard e-commerce architecture.
- Product catalog. The marketplace lists over 70,000 prescription-free items, including medications, vitamins, minerals, sports nutrition, and skincare [TechCrunch].
- Pricing mechanism. Onfy claims prices are 20 to 60 percent lower than recommended retail prices on average, with discounts of up to 75% possible on select products [TechCrunch, gutschein.coupert.com].
- Consumer features. The site includes detailed product pages, customer reviews (some with over 1,200 ratings), and a blog with health-related content [onfy.de].
Data Accuracy: YELLOW -- Core product description confirmed by company website and sponsored press. Specific pricing and catalog size claims are from single, unverified secondary sources.
Market Research and Opportunity
PUBLIC
The German market for non-prescription health products is large and established. Retail channels are shifting gradually but persistently online. This creates an opening for platforms that aggregate supply and demand more efficiently than incumbent pharmacies.
Demand for online access to health and wellness products follows several trends. German consumers are comfortable with e-commerce for everyday goods. This extends to over-the-counter medications, vitamins, and personal care items [TechCrunch].
Home delivery, price transparency, and product comparison drive adoption. An aging population and focus on preventive health contribute too.
The core adjacent market is Germany's pharmacy sector. It is heavily regulated but allows online sales of non-prescription products. The total market was valued at approximately €50 billion in 2023.
Online sales account for a growing share, estimated in the low double-digit percentages [Apotheke Adhoc]. This segment is not a greenfield. A few large players dominate it.
Customer acquisition and supplier onboarding present barriers to entry.
Regulatory forces define the environment. Prescription drugs cannot be sold online to consumers in Germany. Pharmacy-only but non-prescription items can be, if sold by licensed pharmacies.
This framework necessitates a B2B2C model like Onfy's. The platform facilitates transactions between licensed pharmacy partners and end customers.
Macro forces include e-commerce adoption and price sensitivity. Discounts of 20-60% on health essentials appeal, especially amid inflation [TechCrunch].
| Market Segment | Estimated Size (Analogous Market, Source) | Notes |
|---|---|---|
| Total German Pharmacy Market | ~€50B (2023) [Apotheke Adhoc] | Includes all prescription and non-prescription sales through physical and online channels. |
| Online Pharmacy Sales (Germany) | Low double-digit % share of total [Apotheke Adhoc] | The specific online sub-segment Onfy targets. Growth is driven by channel shift. |
This sizing illustrates the substantial total addressable market for health products in Germany. The immediate serviceable market for an online aggregator is smaller and competitive.
Onfy's potential hinges on capturing share from established online pharmacies. Converting offline pharmacy customers to its platform matters too. This is rather than expanding the overall market.
Data Accuracy: YELLOW -- Market sizing figures are cited from industry trade publication Apotheke Adhoc. The TechCrunch article provides directional support for demand drivers but is a sponsored post. No independent third-party market research report (e.g., from Statista, McKinsey) is publicly cited for Onfy's specific opportunity.
Competitive Landscape
MIXED
Onfy enters a German health e-commerce market defined by established online pharmacies and large marketplaces. It positions itself as a pure B2B2C intermediary rather than a direct retailer.
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Onfy | B2B2C marketplace aggregating supply from multiple pharmacies for prescription-free health products. | Founded 2021; funding not disclosed. | Focus on price aggregation and multi-pharmacy sourcing for consumers; partners with Banxware for pharmacy financing. | [Onfy.de]; [TechCrunch] |
| Shop Apotheke | Large, publicly traded online pharmacy and retailer selling directly to consumers. | Public company (SAE.DE); ~€1.8B market cap (April 2025). | Full-service pharmacy with prescription fulfillment, extensive logistics, and a large private label portfolio. | [Apotheke Adhoc] |
| DocMorris | Major online pharmacy, part of the Zur Rose Group, offering prescription and OTC medications. | Public subsidiary; significant scale and marketing spend. | Strong brand recognition, integrated telemedicine services, and a focus on the prescription drug market. | [Apotheke Adhoc] |
| Mycare | Online pharmacy marketplace comparing prices across certified partner pharmacies. | Operated by the Phoenix Group, a major pharmaceutical wholesaler. | Backed by wholesale distribution infrastructure; focuses on price comparison and pharmacy partnerships. | [Apotheke Adhoc] |
| IhreApotheken.de | Cooperative platform for independent brick-and-mortar pharmacies to sell online. | Association model supported by local pharmacy owners. | Network of physical pharmacies offering click & collect; emphasizes local pharmacy support over pure price. | [Apotheke Adhoc] |
The competitive map has three models. Incumbents like Shop Apotheke and DocMorris control inventory, logistics, and customer relationships end-to-end.
Their scale enables aggressive marketing and pricing. They compete directly with independent pharmacies.
Marketplaces like Mycare and IhreApotheken.de aggregate offers from partner pharmacies without holding stock. Onfy fits here. Its B2B2C model suggests deeper backend integration with pharmacy procurement [TechCrunch].
Adjacent substitutes include general e-commerce like Amazon. These lack pharmaceutical certification.
Onfy's edge is positioning as a procurement and financing partner for pharmacies first. It is a discount destination for consumers second.
The Banxware partnership provides digital working capital loans to pharmacy partners [Banxware.com]. This creates potential network effects.
More pharmacy partners increase variety and competition for consumers. A larger consumer base attracts more pharmacies.
This edge is perishable. The financing is a partnership, not proprietary. Marketplace software is replicable.
Durability depends on critical mass in partnerships or loyalty. Incumbents could build or buy similar services.
Exposure to scale and acquisition power of leaders like Shop Apotheke and DocMorris is significant. They have brands, budgets, and pricing power.
Onfy relies on being cheaper. Aggressive incumbent pricing could pressure margins.
Onfy lacks prescription fulfillment. This limits comprehensive platform potential.
Over 18 months, fragmentation may continue. The winner integrates independent pharmacies with smooth consumer experience.
Mycare, with wholesale backing, is positioned well. Smaller aggregators risk loss in price wars.
Onfy's path depends on B2B execution to lock partners before price battles dominate.
Data Accuracy: YELLOW -- Competitor identification and basic positioning are corroborated by industry reports, but detailed funding and scale metrics for competitors are from a single secondary source.
Opportunity
PUBLIC
If Onfy executes its B2B2C model, the prize is a stake in Germany's multi-billion euro market for non-prescription health products. Price sensitivity and digital convenience drive this segment.
The headline opportunity is becoming the primary procurement layer for independent pharmacies. Onfy aggregates demand from small-to-medium pharmacies to secure wholesale pricing.
Individual pharmacies cannot match this. Savings pass to pharmacies and consumers [TechCrunch].
This positions Onfy as a supply chain intermediary. It strengthens local pharmacies against online pure-plays.
Evidence includes 70,000+ products [TechCrunch]. Banxware integration exists [Banxware.com]. Thousands of reviews appear [Onfy.de].
These are foundational for a two-sided network.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Pharmacy Network Dominance | Onfy becomes the default wholesale procurement platform for a critical mass of Germany's ~18,000 pharmacies, moving beyond product sales to become an essential SaaS-enabled supply partner. | A strategic partnership with a major pharmacy cooperative or association, granting Onfy embedded access to a large, pre-existing member base. | The embedded lending partnership with Banxware demonstrates an existing playbook for integrating financial services into the pharmacy workflow, a model that could be replicated for core procurement [Banxware.com]. |
| Vertical Expansion into Adjacent Care | The platform expands beyond OTC medications and supplements to include durable medical equipment, telehealth service integrations, and chronic condition management programs, increasing average order value and customer lifetime value. | Securing a partnership with a telehealth provider or a medical device manufacturer to offer bundled, discounted packages exclusively through Onfy's pharmacy network. | The company's blog already produces detailed health content on conditions like migraines and allergies, indicating an intent to engage consumers on broader healthcare journeys, not just transactional purchases [Onfy.de]. |
What compounding looks like is a marketplace flywheel. More pharmacy partners boost purchasing power and wholesale terms.
Better terms lower prices and improve margins. This attracts more participants.
Banxware embeds financing to reduce frictions [Banxware.com]. This feeds the network.
Success expands to inventory management, marketing, analytics. This locks partners.
The size of the win uses Shop Apotheke as comparable. It reported €1.05 billion revenue in 2023 [Apotheke Adhoc].
Onfy's value anchors to take-rate on GMV. A single-digit percentage of non-prescription market yields hundreds of millions (scenario).
This hinges on pharmacy procurement spend capture. It offers higher margins than retail.
Data Accuracy: YELLOW -- Core model claims are from the company and a sponsored article; partnership with Banxware is confirmed. Scale and traction metrics are from single, unverified secondary sources.
Sources
PUBLIC
[TechCrunch] How Onfy is transforming healthcare for pharmacies and patients | https://techcrunch.com/sponsor/onfy/how-onfy-is-transforming-healthcare-for-pharmacies-and-patients/
[Onfy.de] Impressum | https://onfy.de/impressum
[Bounce Watch] Onfy - E-Commerce, Retail Company Profile | https://bouncewatch.com/explore/startup/onfy
[Banxware.com] Digital Financing for Pharmacies: When Embedded Lending Becomes a Strategic Advantage | https://www.banxware.com/blog/banxware-x-onfy-how-embedded-lending-helps-pharmacies-move-faster-in-a-changing-market
[Medizinfuchs.de] Onfy.de - Marktplatz Versandapotheke Preisvergleich medizinfuchs.de | https://www.medizinfuchs.de/shop-profil/onfy.de--marktplatz-52563.html?params%5Boffset%5D=17
[RocketReach] Onfy Management Team | Org Chart | https://rocketreach.co/onfy-management_b7f6c72cc2a21415
[gutschein.coupert.com] Onfy Rabattcode - 75% Rabatt im Mai 2025 | https://gutschein.coupert.com/store/onfy.de
[LinkedIn] Onfy | LinkedIn | https://de.linkedin.com/company/onfy
[Apotheke Adhoc] Shop Apotheke führt Online-Oligopol | https://www.apotheke-adhoc.de/nachrichten/detail/markt/shop-apotheke-fuehrt-online-oligopol/
[Onfy.de] Über uns | https://onfy.de/uberuns
Articles about Onfy
- Onfy Is Building a Discount Pharmacy Marketplace for 70,000 Health Products — The Berlin startup connects pharmacies directly to manufacturers, aiming to undercut retail prices by up to 60 percent for non-prescription items.